» Articles » PMID: 25026264

Ascophyllan Purified from Ascophyllum Nodosum Induces Th1 and Tc1 Immune Responses by Promoting Dendritic Cell Maturation

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2014 Jul 16
PMID 25026264
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Marine-derived sulfated polysaccharides have been shown to possess certain anti-virus, anti-tumor, anti-inflammatory and anti-coagulant activities. However, the in vivo immunomodulatory effects of marine-derived pure compounds have been less well characterized. In this study, we investigated the effect of ascophyllan, a sulfated polysaccharide purified from Ascophyllum nodosum, on the maturation of mouse dendritic cells (DCs) in vitro and in vivo. Ascophyllan induced up-regulation of co-stimulatory molecules and production of pro-inflammatory cytokines in bone marrow-derived DCs (BMDCs). Moreover, in vivo administration of ascophyllan promotes up-regulation of CD40, CD80, CD86, MHC class I and MHC class II and production of IL-6, IL-12 and TNF-α in spleen cDCs. Interestingly, ascophyllan induced a higher degree of co-stimulatory molecule up-regulation and pro-inflammatory cytokine production than fucoidan, a marine-derived polysaccharide with well-defined effect for promoting DC maturation. Ascophyllan also promoted the generation of IFN-γ-producing Th1 and Tc1 cells in the presence of DCs in an IL-12-dependent manner. Finally, myeloid differentiation primary response 88 (MyD88) signaling pathway was essential for DC maturation induced by ascophyllan. Taken together, these results demonstrate that ascophyllan induces DC maturation, and consequently enhances Th1 and Tc1 responses in vivo. This knowledge could facilitate the development of novel therapeutic strategies to combat infectious diseases and cancer.

Citing Articles

Surface modification strategies for improved hemocompatibility of polymeric materials: a comprehensive review.

Bhattacharjee A, Savargaonkar A, Tahir M, Sionkowska A, Popat K RSC Adv. 2024; 14(11):7440-7458.

PMID: 38433935 PMC: 10906639. DOI: 10.1039/d3ra08738g.


Polysaccharides-Naturally Occurring Immune Modulators.

Murphy E, Fehrenbach G, Abidin I, Buckley C, Montgomery T, Pogue R Polymers (Basel). 2023; 15(10).

PMID: 37242947 PMC: 10222865. DOI: 10.3390/polym15102373.


Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapy.

Kwak H, Hong S, Park H, Park H, Bang Y, Kim J BMC Cancer. 2022; 22(1):1041.

PMID: 36199130 PMC: 9533600. DOI: 10.1186/s12885-022-10140-2.


In Vitro and In Vivo Dendritic Cell Immune Stimulation Effect of Low Molecular Weight Fucoidan from New Zealand .

Liu L, Yang X, Yuan P, Cai S, Bao J, Zhao Y Mar Drugs. 2022; 20(3).

PMID: 35323496 PMC: 8949674. DOI: 10.3390/md20030197.


Advances in plant-derived natural products for antitumor immunotherapy.

Yang Y, Liu Q, Shi X, Zheng Q, Chen L, Sun Y Arch Pharm Res. 2021; 44(11):987-1011.

PMID: 34751930 DOI: 10.1007/s12272-021-01355-1.


References
1.
Cumashi A, Ushakova N, Preobrazhenskaya M, DIncecco A, Piccoli A, Totani L . A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007; 17(5):541-52. DOI: 10.1093/glycob/cwm014. View

2.
Villadangos J, Schnorrer P . Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 2007; 7(7):543-55. DOI: 10.1038/nri2103. View

3.
Kurts C, Kosaka H, Carbone F, Miller J, Heath W . Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med. 1997; 186(2):239-45. PMC: 2198972. DOI: 10.1084/jem.186.2.239. View

4.
Pooley J, Heath W, Shortman K . Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol. 2001; 166(9):5327-30. DOI: 10.4049/jimmunol.166.9.5327. View

5.
Shortman K, Heath W . The CD8+ dendritic cell subset. Immunol Rev. 2010; 234(1):18-31. DOI: 10.1111/j.0105-2896.2009.00870.x. View